Boston-based AcuityMD, a provider of health data tools for the medical technology industry, has recently secured $45 million in funding. This brings the total amount of funding raised by the company to more than $83 million. The funding round was led by ICONIQ Growth, with participation from Stepstone Group, Atreides Management, Benchmark Capital, Artisanal Ventures, and Redpoint Ventures.
With the additional capital, AcuityMD aims to expand its reach with MedTech manufacturers and launch three new products. The company also plans to grow its engineering and product teams by 70% by the end of 2024 to support its mission of accelerating the adoption of cutting-edge medical technology.
In another funding announcement, digital heart and lung disease health startup Eko Health revealed that it has raised $41 million in Series D financing. The funding round saw the participation of ARTIS Ventures, NTTVC, Questa Capital, and Highland Capital Partners. Eko Health combines ECG-enabled digital stethoscope devices with monitoring and analysis algorithms to assist providers in detecting heart rhythm abnormalities and other heart and lung diseases.
With the funds raised through this round, Eko Health plans to scale access to its early disease detection platform globally. CEO and cofounder Connor Landgraf emphasized how Eko Health has revolutionized the medical field by turning the most common medical tool into a powerful early disease detection platform. He highlighted the company’s achievement in creating the world’s largest install base of professional AI-enabled cardiology devices.
